Cricut, Inc.
CRCT Nasdaq Special Industry Machinery, Nec Financials FY2019βFY2025
What Cricut, Inc. does
No business description yet.
- Legal name
- Cricut, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 4, 2026
- Accession Β· CIK
- 0001828962-26-000010
0001828962
Revenue and margins
Cricut, Inc. had $709M of revenue in fiscal 2025, down 0.5% on the year before.
Net income and earnings per share
From fiscal 2019 to 2025, diluted EPS grew 10.7% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Cricut, Inc. returned $227M to shareholders in fiscal 2025. The diluted share count rose 0.8%.
Balance sheet
Cash, debt and the ratios that show how comfortably Cricut, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $242M | $299M | $245M | $337M | $276M |
| Interest coverage | 645.7x | 276.7x | 216.7x | 233.5x | 169.4x |
| Current ratio | 3.0x | 3.2x | 3.2x | 2.9x | 2.3x |
| Quick ratio | 1.5x | 1.7x | 1.7x | 2.2x | 1.7x |
| Total assets | $1.0B | $950M | $750M | $693M | $581M |
| Total liabilities | $332M | $277M | $215M | $226M | $237M |
| Shareholders' equity | $674M | $673M | $535M | $467M | $344M |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β |
| F-score | β / 3 | β / 5 | 3 / 8 | 5 / 8 | 7 / 8 | 7 / 8 | 6 / 8 |
| Accruals ratio | β | β16.1% | 30.9% | β5.8% | β27.6% | β28.0% | β19.4% |
| Altman Z'' | β | 4.14 | 7.31 | 6.97 | 7.06 | 6.47 | 5.80 |
7 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | $487M | $959M | $1.3B | $886M | $765M | $713M | $709M |
| Gross profit | $142M | $332M | $457M | $350M | $343M | $353M | $390M |
| Research and development | $26.7M | $38.9M | $79.8M | $76.9M | $65.0M | $60.4M | $66.5M |
| Operating income | $53.6M | $201M | $192M | $80.0M | $70.0M | $76.1M | $96.0M |
| Interest expense | β | β | $0.3M | $0.3M | $0.3M | $0.3M | $0.6M |
| Pretax income | $50.3M | $199M | $192M | $82.0M | $79.8M | $88.9M | $108M |
| Income tax | $11.1M | $44.6M | $51.9M | $21.3M | $26.1M | $26.0M | $31.2M |
| Net income | $39.2M | $155M | $140M | $60.7M | $53.6M | $62.8M | $76.7M |
| Diluted EPS | $0.19 | $0.74 | $0.64 | $0.28 | $0.24 | $0.29 | $0.35 |
| Diluted shares | 0.21B | 0.21B | 0.22B | 0.22B | 0.22B | 0.22B | 0.22B |
| Cash flow | |||||||
| Cash from operations | $3.9M | $248M | β$105M | $118M | $288M | $265M | $200M |
| Depreciation and amortization | $9.2M | $14.1M | $19.4M | $27.0M | $30.0M | $29.0M | $24.4M |
| Stock-based compensation | $1.8M | $9.5M | $38.1M | $41.1M | $47.3M | $45.1M | $34.8M |
| Share buybacks | β | $0.0M | $0.0M | $18.6M | $20.3M | $38.5M | $24.7M |
| Dividends paid | $0.0M | $51.2M | $0.0M | $0.0M | $294M | $110M | $202M |
| Dividends and buybacks | $0.0M | $51.2M | $0.0M | $18.6M | $314M | $148M | $227M |
| Balance sheet | |||||||
| Cash and short-term investments | $6.7M | $122M | $242M | $299M | $245M | $337M | $276M |
| Current assets | β | $539M | $928M | $811M | $620M | $580M | $500M |
| Current liabilities | β | $347M | $308M | $254M | $196M | $203M | $221M |
| Inventory | β | $249M | $454M | $381M | $278M | $134M | $114M |
| Property and equipment, net | β | $33.4M | $53.3M | $63.4M | $47.6M | $37.5M | $40.3M |
| Intangible assets | β | $2.3M | $1.5M | $0.8M | $0.0M | β | β |
| Total assets | β | $581M | $1.0B | $950M | $750M | $693M | $581M |
| Total liabilities | β | $352M | $332M | $277M | $215M | $226M | $237M |
| Preferred stock | β | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $121M | $229M | $674M | $673M | $535M | $467M | $344M |
| Margins | |||||||
| Gross margin | 29.3% | 34.7% | 35.0% | 39.5% | 44.9% | 49.5% | 55.1% |
| Operating margin | 11.0% | 20.9% | 14.7% | 9.0% | 9.1% | 10.7% | 13.5% |
| EBITDA margin | 12.9% | 22.4% | 16.2% | 12.1% | 13.1% | 14.8% | 17.0% |
| Net margin | 8.1% | 16.1% | 10.8% | 6.8% | 7.0% | 8.8% | 10.8% |
| Returns | |||||||
| Return on capital employed | β | 85.4% | 27.6% | 11.5% | 12.6% | 15.5% | 26.7% |
| Return on equity | 32.4% | 88.3% | 31.1% | 9.0% | 8.9% | 12.5% | 18.9% |
| Return on assets | β | 26.6% | 17.7% | 6.2% | 6.3% | 8.7% | 12.0% |
| Return on tangible equity | 32.4% | 68.2% | 20.9% | 9.0% | 10.0% | 13.5% | 22.3% |
| Growth | |||||||
| Revenue growth | β | 97.1% | 36.2% | β32.1% | β13.7% | β6.9% | β0.5% |
| Net income growth | β | 294.2% | β9.1% | β56.8% | β11.6% | 17.1% | 22.1% |
| EPS growth | β | 289.5% | β13.5% | β56.3% | β14.3% | 20.8% | 20.7% |
| Share count change | β | 0.0% | 5.6% | 0.4% | β0.4% | β1.9% | 0.8% |
| Financial health | |||||||
| Interest coverage | β | β | 645.7x | 276.7x | 216.7x | 233.5x | 169.4x |
| Current ratio | β | 1.6x | 3.0x | 3.2x | 3.2x | 2.9x | 2.3x |
| Quick ratio | β | 0.8x | 1.5x | 1.7x | 1.7x | 2.2x | 1.7x |
| Capital allocation | |||||||
| Stock comp / revenue | 0.4% | 1.0% | 2.9% | 4.6% | 6.2% | 6.3% | 4.9% |
| Quality scores | |||||||
| Piotroski F-score | β | β | 3.0 | 5.0 | 7.0 | 7.0 | 6.0 |
| Altman Z'' | β | 4.1 | 7.3 | 7.0 | 7.1 | 6.5 | 5.8 |
| Accruals ratio | β | β16.1% | 30.9% | β5.8% | β27.6% | β28.0% | β19.4% |
Source: SEC EDGAR XBRL filings (CIK 0001828962). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.